Global Innovative Platforms Inc. · OTC:GIPL
Global Innovative Platforms — Investor Presentation (March 2026)
21 slides from Global Innovative Platforms's investor presentation, Mar 31, 2026
Slide 1: VetBreath Analytics (VBA): A Diagnostic Revolution
VetBreath’ Analytics (VBA) A Division Of Global Innovative Platforms Inc. (OTC: GIPL) A Diagnostic Revolution
Slide 2: Forward Looking Statements
Forward Looking Statements This presentation includes "forward-looking statements.” To the extent that the information presented in this presentation discusses financial projections, information, or expectations about our business plans, results of operations, products or markets, or otherwise makes
Slide 3: Breathomics
Breathomics The study of volatile organic compo exhaled breath. Metabolism produ: predictably with disease states. “breath signature” that can be us diagnostic tool. :
Slide 4: How It Works
HOW IT WORKS VOCs are exhaled in specific combinations and proportions, producing a distinct “breath marker” Disease states produce specific combinations of volatile organic compounds, Gas chromatography unit detects Disease-specific VOC breath markers Results communicated back to clinic staff withi
Slide 5: Using Breathomics to Diagnose Heartworm Disease
USING BREATHOMICS TO DIAGNOSE HEARTWORM DISEASE An Ideal Animal Health Starting Point AHS RECOMMENDATIONS The American Heartworm Society recommends that all dogs 6 months and older be tested annually for heartworm di Current Jard is a blood test. 6 MONTH DETECTION LAG INFECTION DETECTION > > > ) ) o
Slide 6: Heartworm Diagnostics
HEARTWORM DIAGNOSTICS Traditional Breathomics _ <u ¢ Invasive ¢ Non-invasive ¢ Specialized skills ¢ Nospecialized training ¢ Blood samples ¢ Noreagents or other consumables ¢ Ongoing consumables ¢ Results in minutes ¢ Risk of human needle sticks
Slide 7: Why Is Early Detection Important?
WHY IS EARLY DETECTION IMPORTANT? Identify heartworm before lasting damage occurs Protect the heart and lungs from irreversible harm Act early with prevention instead of costly treatment Reduce financial burden and medical risk for owners Provide veterinarians with the first early-stage screening to
Slide 8: The VetBreath Dx Platform
The VetBreath Dx” Platform (Patent Pending) PPT Sensitivity Proprietary Technology Military Research Combines gas chromatography and photoionization detection for high-sensitivity VOC analysis" GIPL controls proprietary, worldwide rights to deploy the technology platform for animal health applicatio
Slide 9: Massive Market Opportunity
MASSIVE MARKET OPPORTUNITY $3B+ Current $3B+ animal diagnostics market’ 6.8% Animal diagnostics market growth’ aoe Target: 30K+ veterinary practices in US & 4K Animal Shelters * Practices 19M annual heartworm tests reported in the US ° CAPC estimates over 60M tests are performed annually in the US o
Slide 10: The Veterinary Value Proposition
b. THE VETERINARY VALUE PROPOSITION Utilize preventives instead of costly, high-risk treatments. No blood draws; reduces needle-stick risk and improves staff safety. Fast results enable same-visit prescriptions and higher client compliance. Full parasite panel will minimize or eliminate the need for
Slide 11: Vet Practice Ownership
VET PRACTICE OWNERSHIP 30,000+ VETERINARY PRACTICES IN U.S. (2025) LARGE GROUP OWNERS _ ae 6,700+ CLINICS CAREVET (200) PETVET (450) THRIVE (455) MARS (2500) MISSION (850) NVA (1500) VETCOR (850) *AS AQUISITIONS OCCUR, ALL NUMBERS ARE APPROXIMATIONS
Slide 12: A Scalable Hardware/Software Enabled Solution
A SCALABLE HARDWARE/SOFTWARE ENABLED SOLUTION HEARTWORM MARKET (ONLY) AVERAGE TESTING CLINICS PROJECTED TO GENERATE $20,800 ANNUAL REVENUE HEARTWORM TEST FOR VBA WHEN PERFORMING 10 TESTS COST TO PRACTICE PER DAY (5 DAYS PER WEEK) is
Slide 13: A Scalable Hardware/Software Enabled Solution
A SCALABLE HARDWARE/SOFTWARE ENABLED SOLUTION COMPLETE PARASITE PANEL (5 TESTS) AVERAGE FULL PANEL TEST AVERAGE LOCATION GENERATES $91,000 ANNUAL REVENUE FOR VBA WHEN PERFORMING 10 PANELS PER DAY (5 DAYS PER WEEK) COST TO PRACTICE } $91,000
Slide 14: Initial Fundraising
INITIAL FUNDRAISING RAISED $1.5M AND. SEEKING INVESTMENTS FOR RESEARCH AND. SCALING CANINE BREATH CAPTURE DEVICE DEVELOPED PROTOTYPE FOR BREATH SAMPLE CAPTURE IN DOGS PROVEN TRACTION RESEARCH PARTNERSHIP ESTABLISHED PARTNERSHIPS WITH LEADING VETERINARY PARASITOLOGISTS AND RESEARCH FACILITIES DEVELOP
Slide 15: Plug and Play
PLUGANDPLAY VBA was vetted and selected from startups around the world to participate in Plug and Play’s Accelerator Program for 2026. Plug and Play has been ranked as one of the most active investors in the world Plug and Play Investment Highlights: © ~250 investments per year © 2.5K+ portfolio com
Slide 16: Launch Schedule
LAUNCH SCHEDULE ¢ COMPLETE MATURE HW MARKER ¢ COMPLETE EARLY HW MARKER ¢ CONTINUE COMMERCIALIZATION ¢ COMPLETE ACCURACY TESTING FOR HW ¢ ADDITIONAL DISEASE R&D AND EXPANSION ¢ INITIATE ADDITIONAL INTESTINAL PARASITE R&D ¢ COMPLETE FULL PARASITE PANEL ¢ BEGIN COMMERCIALIZATION
Slide 17: Future Opportunities
FUTURE OPPORTUNITIES* CHRONIC KIDNEY DISEASE wo f > Affects up to 30-40% of senior cats | and is a leading cause of death Current diagnosis is late Early detection could enable: AVIAN INFLUENZA > ~200M birds lost since 2022" Current diagnosis is late Early detection could enable: Earlier isolation P
Slide 18: Team
TEAM Andrew Brown: Founder and CEO ‘Andrew Brown - Andrew began his last venture in 2006 as a pioneer of delivery service “red He and Delivery to become a national brand and to a successful exit in 2019. The company sold as part ‘of a $32IM transaction to a public company. Dr. Lindsay Starkey: Paras
Slide 19: Citations
Citations L.https://pubs.acs.org/doi/10.1021/acsnano.6b04930? 2.https://www.nature.com/articles/s41598-025-11365-4? 3.https://www.sciencedirect.com/science/article/abs/pii/$1056872721002397? 4.https://www.accessdata.fda.gov/cdrh_docs/pdfl0/P100025b.pdf? 5.https://jamanetwork.com/journals/jamanetwork
Slide 20: Contact Us
CONTACT US ANDREW BROWN - CEO ¢ 321.230.3739 ¢ Andrew@GIPLinc.com CAPTAIN - CHIEF BARK OFFICER
Slide 21: VetBreath Analytics: Pioneering Breath-Based Diagnostics for Animal Health
VeTBREATH PIONEERING BREATH-BASED ANALYTICS DIAGNOSTICS FOR ANIMAL HEALTH a division of Global Innovative Platforms: OVERVIEW: VetBreath™ Analytics is an early-stage, publicly traded animal health diagnostics company developing a non-invasive, breath-based disease detection platform for veterinary u
Global Innovative Platforms — Investor Presentation (March 2026) on 6ix